Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Vical provides clinical update of Allovectin-7 in treatment of head and neck cancer

Nov. 18, 1998

Study shows Zadaxin plus chemotherapy inhibits cancerous tumors in mice

Nov. 18, 1998

New Maxamine data to be presented at annual symposium

Nov. 18, 1998

Protein Design Labs grants patent license to Genentech

Nov. 16, 1998

Axis Genetics and Biomira collaborate on the development of a cancer vaccine

Nov. 16, 1998

AltaRex seeks permission to study immunological activity of OvaRex in phase II trial

Nov. 11, 1998

AltaRex moves to conduct clinical trial with OvaRex in more advanced ovarian cancer

Nov. 6, 1998

Adoptive immunotherapy of cancer with HSPs covered by U.S. patent

Nov. 4, 1998

Ribi ImmunoChem withdraws European Melacine application; focuses on U.S. and Canada

Nov. 3, 1998

FDA okays U.S. portion of multinational study evaluating Theratope

Nov. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...